They produce antiviral compounds—like flavonoids, alkaloids, and terpenoids—that can block viral replication, inhibit key enzymes, and strengthen immune defenses. These natural metabolites are now being explored as potential tools for future drug development. How they work Secondary metabolites from fungi, plants, and endophytic microbes disrupt the virus at multiple points—blocking entry, halting replication, and modulating the immune response. Some phytochemicals even bind directly to SARS-CoV-2’s main protease and spike proteins. Natural sources Mushrooms such as Ganoderma lucidum (reishi) and Phellinus igniarius reduce inflammation and suppress viral replication. Plant compounds like quercetin and baicalein have also been shown to block key coronavirus enzymes. Beyond COVID-19 Traditional medicinal plants—Nigella sativa, Artemisia annua, and Houttuynia cordata, to name a few—have demonstrated antiviral activity against a range of coronaviruses, making them relevant for future pandemic readiness. Research-backed In-silico modeling, lab tests, and early-stage clinical trials all support the idea that these natural compounds can interfere with the viral life cycle—and could be a powerful piece of the antiviral toolkit moving forward.